A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease
Nutrition, Metabolism and Cardiovascular Diseases · 2025
DOI: 10.1016/j.numecd.2025.104206 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Alessandro Mantovani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di V…. Hauptthemen laut MEDLINE: Ceramides, Coronary Artery Disease, Myocardial Infarction, Decision Support Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIM: Plasma ceramides (Cer) are associated with adverse cardiovascular outcomes in patients with coronary artery disease (CAD). We examined whether a newly developed plasma ceramide-based risk score (CER24 score) performs better than CERT1 risk score in predicting adverse cardiovascular outcomes in patients with known or suspected CAD. METHODS AND RESULTS: We followed 167 ambulatory patients undergoing stress myocardial perfusion scintigraphy (MPS) for clinical reasons for a median of 6 years. For the CER24 risk score calculation, we measured plasma Cer(d16:1/24:1)/Cer(d16:1/24:0), Cer(d18:0/24:1)/Cer(d18:0/24:0), Cer(d18:1/24:1)/Cer(d18:1/24:0), Cer(d18:2/24:1)/Cer(d18:2/24:0), and Cer(d20:1/24:1)/Cer(d20:1/24:0), both before and after stress MPS, using a targeted liquid chromatography-tandem mass spectrometry assay. Pre-stress CER24 risk categories (high vs. low/moderate risk) at baseline were associated with a ∼3-fold higher risk of developing the primary composite outcome (defined as all-cause mortality or nonfatal myocardial infarction) even after adjustment for age, sex, smoking, diabetes, pre-existing CAD, left ventricular ejection fraction, and stress-induced inducible myocardial ischemia on MPS (adjusted-hazard ratio 3.06, 95 %CI 1.63-5.77; p = 0.001). Post-stress CER24 risk categories yielded similar results. CER24 high-risk category performed better than CERT1 high-risk category in predicting the primary composite outcome (AUCs = 0.647 vs. 0.580; p = 0.048). CONCLUSIONS: The CER24 score is associated with a higher risk of the composite outcome and performs better than CERT1 score in predicting the risk of dying or developing nonfatal cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy. Electronic address: alessandro.mantovani@univr…
- Division of Cardiology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
- Clinical Analysis Laboratory and Transfusional Medicine, Clinical Pharmacology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
- Division of Nuclear Medicine, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
- Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
Zitieren
APA
Mantovani, A., Bonapace, S., Morandin, R., Sani, E., Lunardi, G., Salgarello, M., Molon, G., & Targher, G. (2025). A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104206
Vancouver
Mantovani A, Bonapace S, Morandin R, Sani E, Lunardi G, Salgarello M, et al. A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104206
BibTeX
@article{Mantovani2025,
author = {Mantovani, Alessandro and Bonapace, Stefano and Morandin, Riccardo and Sani, Elena and Lunardi, Gianluigi and Salgarello, Matteo and Molon, Giulio and Targher, Giovanni},
title = {A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.numecd.2025.104206}
}
EUVIMED